Insulin Glargine U300 vs Insulin Degludec U100 in Impact on the Glycaemic and Cardiovascular Factors

Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: Degludec;   Drug: Glargine U300 Sponsors:   University of Split, School of Medicine;   Pavle Vrebalov Cindro;   Jonatan Vuković;   Darko Modun;   Božo Smajić;   Gordan Kardum;   Tina Tičinović Kurir;   Doris Rušić;   Ana Šešelja Perišin;   Josipa Bukić Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials